Xenetic Biosciences, Inc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Xenetic Biosciences, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2023.
  • Xenetic Biosciences, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
  • Xenetic Biosciences, Inc. annual Operating Lease, Payments for 2023 was $0.000, a 100% decline from 2022.
  • Xenetic Biosciences, Inc. annual Operating Lease, Payments for 2022 was $27K, a 23.8% decline from 2021.
  • Xenetic Biosciences, Inc. annual Operating Lease, Payments for 2021 was $35.5K, a 26.4% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0 -$9.48K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q1 2022 $9.48K +$1.06K +12.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $8.41K +$1.59K +23.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $6.82K Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.